|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 107, Issue 1 205-211, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
G Hunt, C Todd, JE Cresswell and AJ Thody
Department of Dermatology, University of Newcastle upon Tyne, UK.
Although melanocyte stimulating hormone (MSH) peptides are known to stimulate pigmentation in man, previous reports suggest that human melanocytes are relatively unresponsive to these peptides in vitro. This may be related to the conditions under which the melanocytes were cultured. Thus, we have re-investigated the in vitro effects of MSH peptides using human melanocytes cultured in the absence of artificial mitogens. Human melanocytes were incubated with alpha-MSH or its potent analogue Nle4Dphe7 alpha-MSH for 3 days. After 18 hours, melanocyte morphology had evolved from mainly bipolar to dendritic in approximately 66% of cultures. Nle4DPhe7 alpha-MSH produced dose-related increases in both tyrosinase activity and melanin content although the degree of response was variable and tyrosinase activity was the relatively more responsive to the peptide. Similar results were obtained with alpha-MSH, but, although the effect on melanin content was similar to that of Nle4DPhe7 alpha-MSH, the effect on tyrosinase activity was less marked. The preliminary EC50 values for the actions of the MSH peptides suggest that they may be equipotent in their actions on human melanocytes. In addition, we have demonstrated that the common melanocyte mitogens 12-O-tetradecanoyl phorbol-13-acetate (TPA) and cholera toxin affect basal melanogenesis and modulate the effects of the MSH peptides. However, not all melanocyte cultures showed melanogenic responses to the MSH peptides. Ability to respond was unrelated to basal levels of tyrosinase activity or melanin content. In at least some cultures, morphological and melanogenic responses appear to be independent of one another.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  K. Rousseau, S. Kauser, L. E. Pritchard, A. Warhurst, R. L. Oliver, A. Slominski, E. T. Wei, A. J. Thody, D. J. Tobin, and A. White Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis FASEB J, June 1, 2007; 21(8): 1844 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li, D.-N. Hu, H. Zhao, S. A. McCormick, J. J. Nordlund, and R. E. Boissy Uveal Melanocytes Do Not Respond To or Express Receptors for {alpha}-Melanocyte-Stimulating Hormone. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4507 - 4512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dumaz, R. Hayward, J. Martin, L. Ogilvie, D. Hedley, J. A. Curtin, B. C. Bastian, C. Springer, and R. Marais In Melanoma, RAS Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling Cancer Res., October 1, 2006; 66(19): 9483 - 9491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Amsen, N. Pham, Y. Pak, and D. Rotin The Guanine Nucleotide Exchange Factor CNrasGEF Regulates Melanogenesis and Cell Survival in Melanoma Cells J. Biol. Chem., January 6, 2006; 281(1): 121 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C W Wong, Y S Fan, T L Chan, A S W Chan, L C Ho, T K F Ma, the Cancer Genome Project, S T Yuen, and S Y Leung BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs J. Clin. Pathol., June 1, 2005; 58(6): 640 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kauser, A. J. Thody, K. U. Schallreuter, C. L. Gummer, and D. J. Tobin A Fully Functional Proopiomelanocortin/Melanocortin-1 Receptor System Regulates the Differentiation of Human Scalp Hair Follicle Melanocytes Endocrinology, February 1, 2005; 146(2): 532 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation Physiol Rev, October 1, 2004; 84(4): 1155 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. KADEKARO, H. KANTO, R. KAVANAGH, and Z. A. ABDEL-MALEK Significance of the Melanocortin 1 Receptor in Regulating Human Melanocyte Pigmentation, Proliferation, and Survival Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 359 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-S. Kim, E.-S. Hwang, J.-E. Lee, S.-Y. Kim, S.-B. Kwon, and K.-C. Park Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation J. Cell Sci., May 1, 2003; 116(9): 1699 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Khaled, L. Larribere, K. Bille, E. Aberdam, J.-P. Ortonne, R. Ballotti, and C. Bertolotto Glycogen Synthase Kinase 3beta Is Activated by cAMP and Plays an Active Role in the Regulation of Melanogenesis J. Biol. Chem., September 6, 2002; 277(37): 33690 - 33697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tsatmali, J. Ancans, and A. J. Thody Melanocyte Function and Its Control by Melanocortin Peptides J. Histochem. Cytochem., February 1, 2002; 50(2): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. BANDYOPADHYAY and E. E. MEDRANO Melanin Accumulation Accelerates Melanocyte Senescence by a Mechanism Involving p16INK4a/CDK4/pRB and E2F1 Ann. N.Y. Acad. Sci., June 1, 2000; 908(1): 71 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. ABDEL-MALEK, I. SUZUKI, A. TADA, S. IM, and C. AKCALI The Melanocortin-1 Receptor and Human Pigmentation Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 117 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. THODY {alpha}-MSH and the Regulation of Melanocyte Function Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 217 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bertolotto, P. Abbe, T. J. Hemesath, K. Bille, D. E. Fisher, J.-P. Ortonne, and R. Ballotti Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes J. Cell Biol., August 10, 1998; 142(3): 827 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Buscà, C. Bertolotto, P. Abbe, W. Englaro, T. Ishizaki, S. Narumiya, P. Boquet, J.-P. Ortonne, and R. Ballotti Inhibition of Rho Is Required for cAMP-induced Melanoma Cell Differentiation Mol. Biol. Cell, June 1, 1998; 9(6): 1367 - 1378. [Abstract] [Full Text]
|
|
|
|
|
|
W. Englaro, C. Bertolotto, R. Busca, A. Brunet, G. Pages, J.-P. Ortonne, and R. Ballotti Inhibition of the Mitogen-activated Protein Kinase Pathway Triggers B16 Melanoma Cell Differentiation J. Biol. Chem., April 17, 1998; 273(16): 9966 - 9970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bertolotto, R. Buscà, P. Abbe, K. Bille, E. Aberdam, J.-P. Ortonne, and R. Ballotti Different cis-Acting Elements Are Involved in the Regulation of TRP1 and TRP2 Promoter Activities by Cyclic AMP: Pivotal Role of M Boxes (GTCATGTGCT) and of Microphthalmia Mol. Cell. Biol., February 1, 1998; 18(2): 694 - 702. [Abstract] [Full Text]
|
|
|
|
|
|
R. Busca, C. Bertolotto, J.-P. Ortonne, and R. Ballotti Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation J. Biol. Chem., December 13, 1996; 271(50): 31824 - 31830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Romero-Graillet, E. Aberdam, N. Biagoli, W. Massabni, J.-P. Ortonne, and R. Ballotti Ultraviolet B Radiation Acts through the Nitric Oxide and cGMP Signal Transduction Pathway to Stimulate Melanogenesis in Human Melanocytes J. Biol. Chem., November 8, 1996; 271(45): 28052 - 28056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Chluba-de Tapia, C Bagutti, R Cotti, and A. Eberle Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene J. Cell Sci., January 8, 1996; 109(8): 2023 - 2030. [Abstract] [PDF]
|
|
|
|
|
|
W. Englaro, R. Rezzonico, M. Durand-Clément, D. Lallemand, J.-P. Ortonne, and R. Ballotti Mitogen-activated Protein Kinase Pathway and AP-1 Are Activated during cAMP-induced Melanogenesis in B-16 Melanoma Cells J. Biol. Chem., October 13, 1995; 270(41): 24315 - 24320. [Abstract] [Full Text] [PDF]
|
|
